Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.00175-07PMID 17526760PMCID PMC2151409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

  2006cited by this paper
• Risk Factors for Buruli Ulcer, Benin

  2006cited by this paper
• Mycobacterium ulcerans infection: control, diagnosis, and treatment.

  2006cited by this paper
• Buruli ulcer situation in Benin

  2005cited by this paper
• Buruli Ulcer Recurrence, Benin

  2005cited by this paper
• Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans

  2005cited by this paper
• Mycobacterium bovis BCG Vaccination as Prophylaxis against Mycobacterium ulcerans Osteomyelitis in Buruli Ulcer Disease

  2004cited by this paper
• Isolation of Three Mycobacterium ulcerans Strains Resistant to Rifampin after Experimental Chemotherapy of Mice

  2003cited by this paper
• Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin.

  2003influential reference
• The Buruli mysteries: unanswered questions surround a growing epidemic.

  2002cited by this paper
• Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

  2002cited by this paper
• Activities of New Macrolides and Fluoroquinolones against Mycobacterium ulcerans Infection in Mice

  2001cited by this paper
• Activities of Several Antimicrobials againstMycobacterium ulcerans Infection in Mice

  2000cited by this paper
• A Simple PCR Method for Rapid Genotype Analysis ofMycobacterium ulcerans

  2000cited by this paper
• In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.

  2000cited by this paper
• A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

  2000cited by this paper
• Mycobacterium ulcerans infection.

  1999cited by this paper
• Identification and Characterization of IS2404 and IS2606: Two Distinct Repeated Sequences for Detection of Mycobacterium ulcerans by PCR

  1999cited by this paper
• Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

  1999cited by this paper
• Effectiveness of Excision of Pre-Ulcerative Buruli Lesions in Field Situations in a Rural District in Ghana

  1998cited by this paper
• In Vitro Susceptibility of Mycobacterium ulcerans to Clarithromycin

  1998cited by this paper
• Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection

  1997cited by this paper
• Buruli ulcer in Benin.

  1990cited by this paper
• Toxin of Mycobacterium ulcerans.

  1974cited by this paper
• Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skin.

  1974cited by this paper
• A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.

  1973cited by this paper

• Comparative analysis of Buruli ulcer in Ghana and Côte d’Ivoire: A cross-sectional study

  2026cites this paper
• Numerical treatment of fractional order Buruli ulcer and cholera model by using neural network approach

  2025cites this paper
• Antimicrobial resistant bacteria isolated from Buruli ulcer lesions in Ghana

  2025influential citation
• Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection

  2024cites this paper
• A Computational Neural Network Framework for Fractional-Order Modeling of Buruli Ulcer and Cholera: Insights into Microbial Genetics and Pathogenesis

  2024cites this paper
• Screening anti-infectious molecules against Mycobacterium ulcerans : a step 2 towards decontaminating environmental specimens.

  2023cites this paper
• Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans

  2023cites this paper
• Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Côte d’Ivoire

  2023cites this paper
• Integrated Management Strategies (Diagnosis, Treatment, and Wound Care Management) for Improved Clinical Outcomes of Buruli Ulcer in Ghana: A Retrospective Case Report in the Ga West Municipal Hospital, Amasaman

  2022cites this paper
• Serum lipoproteins and lipoarabinomannan suppress the inflammatory response induced by the mycolactone toxin

  2022cites this paper
• (Part 2) Molecular characterization of Mycobacterium ulcerans DNA gyrase and identification of mutations reduced susceptibility to quinolones in vitro

  2022cites this paper
• Patient Care and Treatment Strategies for Skin Diseases in Sub Saharan Africa: Role of Traditional and Western Medicines.

  2022cites this paper
• Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In Vitro

  2022cites this paper
• Caregiver burden in Buruli ulcer disease: Evidence from Ghana

  2021cites this paper
• Ketogenic diet impairs Mycobacterium ulcerans growth and toxin production, enhancing hosts' response to the infection in an experimental mouse model.

  2021cites this paper
• Molecular characterization of Mycobacterium ulcerans DNA gyrase and identification of mutations reduced susceptibility against quinolones in vitro

  2021cites this paper
• A mathematical model for the coinfection of Buruli ulcer and Cholera

  2021cites this paper
• Buruli Ulcer

  2020cites this paper
• Screening anti-infectious molecules against Mycobacterium ulcerans: A step towards decontaminating environmental specimens

  2020cites this paper
• Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology

  2020cites this paper
• Buruli ulcer: cured by 8 weeks of oral antibiotics?

  2020cites this paper
• Mycobactérioses cutanées dues à Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium abscessus, Mycobacterium chelonae et autres mycobactéries non tuberculeuses

  2020cites this paper
• Laboratory Diagnosis of Buruli Ulcer: Challenges and Future Perspectives

  2019cites this paper
• Secondary Infection of Buruli Ulcer Lesions

  2019cites this paper
• Buruli Ulcer: History and Disease Burden

  2019cites this paper
• Recombinant Antibodies against Mycolactone

  2019cites this paper
• Management of Buruli Ulcer/HIV co-infection in a Resource Limited Setting: A Case Report

  2019cites this paper
• Evaluation of the antimycobacterial and antimycolactone efficaciousness of kombucha

  2019cites this paper
• Antimicrobial Treatment of Mycobacterium ulcerans Infection

  2019cites this paper
• Mycobacterium ulcerans Disease: Buruli Ulcer

  2019cites this paper
• The gendered impact of Buruli ulcer on the household production of health and social support networks: Why decentralization favors women

  2019cites this paper
• Aloe vera: a promising hope against Buruli ulcer

  2019cites this paper
• Cutaneous Infections Due to Nontuberculosis Mycobacterium: Recognition and Management

  2018cites this paper
• Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

  2018cites this paper
• Developing a Buruli ulcer community of practice in Bankim, Cameroon: A model for Buruli ulcer outreach in Africa

  2018cites this paper
• Mycobacterium ulcerans disease management in Australian patients: the re‐emergence of surgery as an important treatment modality

  2018cites this paper
• Mycobacterium Nontuberculosis Species

  2018cites this paper
• Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016

  2018cites this paper
• Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial.

  2018cites this paper
• Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening

  2018cites this paper
• Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa

  2018cites this paper
• PCR detection of Mycobacterium ulcerans—significance for clinical practice and epidemiology

  2018cites this paper
• Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection

  2018cites this paper
• An Overview of the Treatment of Mycobacterium ulcerans Infection (Buruli Ulcer)

  2018cites this paper
• Challenges associated with the treatment of Buruli ulcer

  2018cites this paper
• Modeling the Transmission and Prevention of Infectious Disease

  2017cites this paper
• Buruli Ulcer: Case Study of a Neglected Tropical Disease

  2017cites this paper
• Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

  2017cites this paper
• Occurrence and Distribution of Mycobacterium Ulcerans along the Densu and Offin River Basins of Ghana

  2017cites this paper
• Discovery of Buruli Ulcer Infection Associated Metabolic Markers

  2017cites this paper
• Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans

  2017cites this paper
• In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials

  2017cites this paper
• Approche ethnobotanique et ethnopharmacologique des plantes utilisées dans le traitement traditionnel de l’ulcère de Buruli à Akonolinga (Cameroun)

  2017cites this paper
• Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review

  2017cites this paper
• Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana

  2016cites this paper
• Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy

  2016cites this paper
• Genotyping and Treatment of Secondary Bacterial Infections among Buruli Ulcer Patients in the Amansie Central District of Ghana

  2016cites this paper
• Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)

  2016influential citation
• Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort

  2016influential citation
• Buruli ulcer: wound care and rehabilitation

  2016cites this paper
• Manifestations cutanéomuqueuses des mycobactéries environnementales (dont Mycobacterium ulcerans)

  2016cites this paper
• Manifestaciones cutaneomucosas de las micobacterias ambientales (incluida Mycobacterium ulcerans)

  2016cites this paper
• Burden and Historical Trend of Buruli Ulcer Prevalence in Selected Communities along the Offin River of Ghana

  2016cites this paper
• Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer

  2016cites this paper
• Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy

  2016cites this paper
• Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer

  2016cites this paper
• Buruli ulcer in Nigeria: results of a pilot case study in three rural districts

  2016cites this paper
• Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts

  2016cites this paper
• Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease

  2015cites this paper
• Development of a Dry-Reagent-Based qPCR to Facilitate the Diagnosis of Mycobacterium ulcerans Infection in Endemic Countries

  2015cites this paper
• Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

  2015cites this paper
• ‘I could not be idle any longer’: buruli ulcer treatment assemblages in rural Ghana

  2015cites this paper
• The Buruli Ulcer

  2015cites this paper
• Detection of Mycolactone by Fluorescent Thin Layer Chromatography (F-Tlc) For the Diagnosis of Buruli Ulcer

  2015influential citation
• Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice.

  2015cites this paper
• Short Convergent Synthesis of the Mycolactone Core Through Lithiation–Borylation Homologations

  2015cites this paper
• Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective.

  2015cites this paper
• Epidemiology and disease burden of Buruli ulcer: a review

  2015cites this paper
• Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts.

  2015cites this paper
• Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan

  2015cites this paper
• The Infectious and Noninfectious Dermatological Consequences of Flooding: A Field Manual for the Responding Provider

  2015cites this paper
• Punaises aquatiques du Cameroun : biodiversité, phylogéographie et rôle dans l’écologie de Mycobacterium ulcerans, agent étiologique de l’ulcère de Buruli

  2015cites this paper
• Buruli ulcer in West Africa: Aspects of patient management

  2015cites this paper
• Health-related quality of life of adult patients healed from Buruli ulcer in Benin.

  2015cites this paper
• Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.

  2015cites this paper
• In-vitro Activity of Avermectins against Mycobacterium ulcerans

  2015cites this paper
• Genetic Diversity of Staphylococcus aureus in Buruli Ulcer

  2015cites this paper
• A Field Study in Benin to Investigate the Role of Mosquitoes and Other Flying Insects in the Ecology of Mycobacterium ulcerans

  2015cites this paper
• Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”

  2014cites this paper
• Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease

  2014cites this paper
• Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease

  2014cites this paper
• Buruli Ulcer (Atypical Mycobacteria)

  2014cites this paper
• Suspected Buruli ulcer of the face: a case report from Ethiopia.

  2014cites this paper
• University of Groningen Contribution of the community health volunteers in the control of buruli ulcer in Bénin Barogui, Yves Thierry; Sopoh, Ghislain Emmanuel; Johnson, Roch Christian; de Zeeuw,

  2014cites this paper
• Management of BU–HIV co‐infection

  2014cites this paper
• Réponses et réactions paradoxales au cours du traitement médicamenteux de l’infection à Mycobacterium ulcerans (ulcère de Buruli). Quatre observations en Guyane française

  2014cites this paper
• Buruli ulcer control in a highly endemic district in Ghana: role of community-based surveillance volunteers.

  2014cites this paper
• Treatment and prevention of Mycobacterium ulcerans infection ( Buruli ulcer ) in Australia : guideline update Guidelines

  2014cites this paper
• Assessing the Effectiveness of a Health Education Campaign for Improving the Awareness and Preventative Health Behaviors of Buruli Ulcer Disease Affecting Cocoa Farmers in the Ashanti Region of Ghana

  2014cites this paper
• Novel phage display libraries and selection technologies for the isolation of fully human antibodies for pharmaceutical applications

  2014cites this paper